Edgar Filing: DENTINO WILLIAM

Ownership Submission

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

DENTINO WILLIAM

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE INC [MOH]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	__X__ 10% Owner
_____ Officer (give title below)	__X__ Other (specify below)
Trustee and executor

(Last)

(First)

(Middle)

3500 DOUGLAS BLVD., SUITE 160

3. Date of Earliest Transaction (Month/Day/Year)
01/17/2018

(Street)

ROSEVILLE, CA 95661

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	01/17/2018		S⁽¹⁾		22,500	D	$ 91.2028 ⁽²⁾	3,061,792	I	Trustee ⁽³⁾
Common Stock	01/18/2018		S⁽¹⁾		22,500	D	$ 92.8388 ⁽⁴⁾	3,039,292	I	Trustee ⁽³⁾
Common Stock	01/19/2018		J⁽⁵⁾	V	3,036,047	D	$ 0 ⁽⁵⁾	3,245	I	Trustee ⁽³⁾
Common Stock								28,258	I	Trustee ⁽⁶⁾
Common Stock	01/19/2018		J⁽⁵⁾	V	254,209	D	$ 0 ⁽⁵⁾	0	I	Trustee ⁽⁷⁾
Common Stock								47,273	I	Executor ⁽⁸⁾
Common Stock	01/19/2018		J⁽⁵⁾	V	208,795	D	$ 0 ⁽⁵⁾	0	I	Trustee ⁽⁹⁾
Common Stock	01/19/2018		J⁽⁵⁾	V	239,381	D	$ 0 ⁽⁵⁾	0	I	Trustee ⁽¹⁰⁾
Common Stock	01/19/2018		J⁽⁵⁾	V	295,750	D	$ 0 ⁽⁵⁾	0	I	Trustee ⁽¹¹⁾
Common Stock	01/19/2018		J⁽⁵⁾	V	344,906	D	$ 0 ⁽⁵⁾	0	I	Trustee ⁽¹²⁾
Common Stock	01/19/2018		J⁽⁵⁾	V	172,990	D	$ 0 ⁽⁵⁾	0	I	Trustee ⁽¹³⁾
Common Stock	01/19/2018		J⁽⁵⁾	V	192,705	D	$ 0 ⁽⁵⁾	0	I	Trustee ⁽¹⁴⁾
Common Stock	01/19/2018		J⁽⁵⁾	V	206,719	D	$ 0 ⁽⁵⁾	0	I	Trustee ⁽¹⁵⁾
Common Stock								300	I	Trustee ⁽¹⁶⁾
Common Stock								1,496	I	Trustee ⁽¹⁷⁾
Common Stock	01/19/2018		J⁽⁵⁾	V	154,291	D	$ 0 ⁽⁵⁾	0	I	Trustee ⁽¹⁸⁾

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
DENTINO WILLIAM 3500 DOUGLAS BLVD., SUITE 160 ROSEVILLE, CA 95661		X		Trustee and executor
PEDERSEN CURTIS 6218 EAST 6TH STREET LONG BEACH, CA 90803		X		Trustee

Signatures

/s/ William Dentino, by Karen Calhoun, Attorney-In-Fact		01/19/2018
^**Signature of Reporting Person		Date
/s/ Curtis Pedersen, by Karen Calhoun, Attorney-In-Fact		01/19/2018
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Sale pursuant to the Rule 10b5-1 Trading Plan of the Mary R Molina Living Trust.
(2)	Represents the weighted average sale price of all sales on the Transaction Date. The range of prices for the transactions was $88.99 to $92.41. The Reporting Person undertakes to provide full information about the transactions to the Commission upon request.
(3)	The shares are owned by the Mary R. Molina Living Trust, of which Mr. Dentino and Mr. Pedersen are co-trustees.
(4)	Represents the weighted average sale price of all sales on the Transaction Date. The range of prices for the transactions was $91.68 to $93.83. The Reporting Person undertakes to provide full information about the transactions to the Commission upon request.
(5)	Distribution to beneficiaries without consideration.
(6)	The shares are owned by the Exempt Mary R. Molina Living Trust, of which Mr. Dentino and Mr. Pedersen are co-trustees.
(7)	The shares are owned by the MRM GRAT 812/3 of which Mr. Dentino and Mr. Pedersen are co-trustees.
(8)	The shares are owned by the Estate of Mary R. Molina, of which Mr. Dentino is executor.
(9)	The shares are owned by MRM GRAT 610/5, of which Mr. Dentino and Mr. Pedersen are co-trustees.
(10)	The shares are owned by the MRM GRAT 609/7, of which Mr. Dentino and Mr. Pedersen are co-trustees.
(11)	The shares are owned by MRM GRAT 1210/4, of which Mr. Dentino and Mr. Pedersen are co-trustees.
(12)	The shares are owned by MRM GRAT 811/3, of which Mr. Dentino and Mr. Pedersen are co-trustees.
(13)	The shares are owned by MRM GRAT 610/4, of which Mr. Dentino and Mr. Pedersen are co-trustees.
(14)	The shares are owned by the MRM GRAT 1209/4, of which Mr. Dentino and Mr. Pedersen are co-trustees.
(15)	The shares are owned by the MRM GRAT 609/4, of which Mr. Dentino and Mr. Pedersen are co-trustees.
(16)	The shares are owned by the Curtis and Rosi Pedersen 2012 Trust, of which Mr. Pedersen and his spouse are co-trustees.
(17)	The shares are owned by the Dentino Family Trust, of which Mr. Dentino is sole trustee.
(18)	The shares are owned by the MRM GRAT 1209/3, of which Mr. Dentino and Mr. Pedersen are co-trustees.
Remarks: See Exhibit 99 for the names, addresses and signatures of Additional Reporting Persons. Such Additional Reporting Persons are also no longer subject to Section 16.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.